{"id":125,"date":"2026-09-08T06:21:50","date_gmt":"2026-09-08T06:21:50","guid":{"rendered":"https:\/\/saluspharmaceuticals.com\/blog\/?p=125"},"modified":"2026-09-08T06:21:50","modified_gmt":"2026-09-08T06:21:50","slug":"what-a-copp-actually-proves-and-what-it-doesnt","status":"publish","type":"post","link":"https:\/\/saluspharmaceuticals.com\/blog\/2026\/09\/08\/what-a-copp-actually-proves-and-what-it-doesnt\/","title":{"rendered":"What a COPP Actually Proves \u2014 And What It Doesn\u2019t"},"content":{"rendered":"<body>\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.saluspharmaceuticals.com\/products.html\"><strong>A Certificate of Pharmaceutical Product<\/strong><\/a> proves three administrative facts and nothing more: that one specific product holds a marketing authorisation in the exporting country, whether that product is actually sold there, and that the site making it has been inspected against<a href=\"https:\/\/www.saluspharmaceuticals.com\/products.html\"><strong> WHO GMP.<\/strong><\/a> It says nothing about the batch in your container. If you are registering an Indian product for the first time, understanding that boundary will save you a rejection and a wasted authentication cycle at your embassy.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><a>One product, one certificate<\/a><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The WHO guidance is explicit that the certificate \u201cis for a single product only since the manufacturing arrangements and approved information for different dosage forms and different strengths can vary.\u201d A 500 mg tablet and a 250 mg tablet of the same molecule are two certificates. A twelve-product order is twelve certificates.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This is where most first enquiries go wrong. Buyers ask a manufacturer to<strong><a href=\"https:\/\/www.saluspharmaceuticals.com\/contact.html\"> \u201csend your COPP\u201d,<\/a><\/strong> expecting a single document covering the factory. That document exists, but it is a different one \u2014 the WHO-GMP certificate, which covers the site and the categories of product licensed there. The CoPP is the product-level certificate built on top of it. Ask for both, and ask for the CoPP product by product against the exact strengths and pack presentations you intend to register.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><a>The three lines an overseas regulator reads first<\/a><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The WHO model certificate runs to several numbered boxes, but a reviewing assessor goes straight to three of them.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Box 1.3<\/strong>\u00a0asks: \u201cIs this product authorized by the certifying authority to be marketed in the certifying country or within the jurisdiction of the certifying regional authority?\u201d A \u201cNo\u201d here is not automatically fatal, but it moves the file into a different queue.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Box 1.4<\/strong>\u00a0asks: \u201cIs this product actually on the market in the certifying country?\u201d \u2014 with Yes, No or Unknown as the permitted answers. This is the box that surprises importers. Plenty of Indian-made products are manufactured for export only. Under the CDSCO export No Objection Certificate route, the manufacturer undertakes that \u201cthe entire quantity\u2026 shall be exported and no part of it will be diverted for domestic sale in India\u201d, and the pack is labelled \u201cFor export only \u2013 Not for domestic consumption.\u201d That is a lawful, documented arrangement \u2014 but it produces a \u201cNo\u201d in box 1.4, and some importing authorities treat that answer as a reason to ask for more.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Box 3.5<\/strong>\u00a0asks whether <a href=\"https:\/\/www.saluspharmaceuticals.com\/infrastructure.html\">\u201cthe facilities and operations of the manufacturer<\/a> of the FPP conform to good manufacturing practices (GMP) as recommended by WHO.\u201d This is the line the certificate exists for. Read it alongside the site\u2019s WHO-GMP certificate and the date of the last inspection.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><a>Who issues it, and how long the process takes<\/a><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">CDSCO administers the WHO certification scheme in India in coordination with the State Licensing Authorities. For a plant in Himachal Pradesh, the application is made to the State Licensing Authority and the inspection is a joint one, carried out by CDSCO zonal or sub-zonal officers together with state representatives.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><a>How long it stays valid \u2014 two answers, not one<\/a><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The WHO guidance leaves validity to the issuing authority: \u201cA period of validity can be provided by the authority on the certificate.\u201d There is no universal expiry.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In Indian practice, WHO-GMP certificates and CoPP have carried a three-year validity since 2018, when the Drugs Controller General extended it from two years. That figure has moved before \u2014 in May 2020 CDSCO extended certificates expiring between March and August 2020 by a further six months \u2014 so verify the dates printed on the actual document rather than assuming the rule.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The validity that constrains you, though, is usually the importing regulator\u2019s. <strong><a href=\"https:\/\/www.saluspharmaceuticals.com\/infrastructure.html\">NAFDAC<\/a><\/strong>, for example, requires that the certificate be issued by the health or regulatory body in the country of manufacture, conform to WHO format, and be authenticated by the Nigerian Embassy or High Commission in the country of origin \u2014 with a Commonwealth or ECOWAS mission acceptable where no Nigerian mission exists. The accompanying cGMP certificate must be \u201cvalid at the time of submission.\u201d Authentication takes weeks. A certificate with eight months left on it can still be too old by the time your dossier is assessed.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><a>What a CoPP does not prove<\/a><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">It does not certify the consignment. WHO deals with individual consignments through a separate instrument \u2014 the batch certificate, which \u201crefers to an individual batch\u201d and is described as a vital instrument in the procurement of medicines. The CoPP is for registration; the batch certificate and certificate of analysis are for the shipment. Treating a CoPP as a quality release is a category error, and it is the one that most often shows up in a first-time importer\u2019s file.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">It also does not attest bioequivalence, stability in your climatic zone, or suitability of the pack for your market. Box 4 asks only whether \u201cthe information submitted by the applicant satisfy the certifying authority on all aspects of the manufacture of the product\u201d \u2014 a statement about that authority\u2019s satisfaction, not a technical opinion you can use in place of data.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><a>Reading a WHO-format CoPP: the boxes that matter<\/a><\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><td>Box<\/td><td>What it asks<\/td><td>What to do with the answer<\/td><\/tr><\/thead><tbody><tr><td>1.3<\/td><td>Is the product authorised to be marketed in the certifying country?<\/td><td>If \u201cNo\u201d, go straight to box 2.B for the reason before anything else<\/td><\/tr><tr><td>1.4<\/td><td>Is the product actually on the market there? (Yes \/ No \/ Unknown)<\/td><td>\u201cNo\u201d is normal for export-only products \u2014 ask for the export NOC and a specimen of the \u201cFor export only\u201d label<\/td><\/tr><tr><td>2.A.1<\/td><td>Marketing authorisation number and date of issue<\/td><td>Check it matches the exact strength and dosage form you are registering, not a sister product<\/td><\/tr><tr><td>2.B<\/td><td>If not authorised, the reason: not required \/ not requested \/ under consideration \/ refused \/ withdrawal for commercial reasons \/ withdrawal for sanitary reasons<\/td><td>\u201cRefused\u201d or \u201cwithdrawal for sanitary reasons\u201d ends the assessment. The others do not<\/td><\/tr><tr><td>3.5<\/td><td>Do the facilities conform to WHO-recommended GMP?<\/td><td>Pair with the site WHO-GMP certificate and the date of the last inspection<\/td><\/tr><tr><td>4<\/td><td>Does the applicant\u2019s submitted information satisfy the certifying authority?<\/td><td>A \u201cNo\u201d here is rare and material \u2014 ask what was outstanding<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">How Salus approaches this<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Salus Pharmaceuticals manufactures at a WHO-GMP and ISO 9001:2015 certified facility in Baddi, Himachal Pradesh, and has done so since 2005. Certification documents are issued product by product through the State Licensing Authority route described above, and export documentation for Nigeria, Bangladesh and Sri Lanka is prepared against each destination regulator\u2019s own authentication and currency requirements rather than as a single standard pack.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Need COPP documentation for your products?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><a href=\"https:\/\/www.saluspharmaceuticals.com\/contact.html\">[Ask for our current CoPP list, product by product \u2192]<\/a><\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.saluspharmaceuticals.com\/contact.html\"><strong>https:\/\/www.saluspharmaceuticals.com\/contact.html<\/strong><\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n<\/body>","protected":false},"excerpt":{"rendered":"<p>A Certificate of Pharmaceutical Product proves three administrative facts and nothing more: that one specific product holds a marketing authorisation in the exporting country, whether that product is actually sold there, and that the site making it has been inspected against WHO GMP. It says nothing about the batch in your container. If you are [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":126,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"pagelayer_contact_templates":[],"_pagelayer_content":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-125","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"jetpack_featured_media_url":"https:\/\/saluspharmaceuticals.com\/blog\/wp-content\/uploads\/2026\/09\/1000043039-scaled.jpg","_links":{"self":[{"href":"https:\/\/saluspharmaceuticals.com\/blog\/wp-json\/wp\/v2\/posts\/125","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/saluspharmaceuticals.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/saluspharmaceuticals.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/saluspharmaceuticals.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/saluspharmaceuticals.com\/blog\/wp-json\/wp\/v2\/comments?post=125"}],"version-history":[{"count":1,"href":"https:\/\/saluspharmaceuticals.com\/blog\/wp-json\/wp\/v2\/posts\/125\/revisions"}],"predecessor-version":[{"id":127,"href":"https:\/\/saluspharmaceuticals.com\/blog\/wp-json\/wp\/v2\/posts\/125\/revisions\/127"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/saluspharmaceuticals.com\/blog\/wp-json\/wp\/v2\/media\/126"}],"wp:attachment":[{"href":"https:\/\/saluspharmaceuticals.com\/blog\/wp-json\/wp\/v2\/media?parent=125"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/saluspharmaceuticals.com\/blog\/wp-json\/wp\/v2\/categories?post=125"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/saluspharmaceuticals.com\/blog\/wp-json\/wp\/v2\/tags?post=125"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}